Wayne C. Anderson

Director/Board Member at EVOME MEDICAL TECHNOLOGIES INC.

Net worth: - $ as of 2024-05-30

Health Technology

Consumer Services

Profile

Wayne C.
Anderson is a Non-Executive Director at Evome Medical Technologies, Inc. He previously served as the President & Chief Executive Officer at Ferring Pharmaceuticals, Inc. from 1997 to 2010.
Mr. Anderson holds an undergraduate degree from The Ohio University and an MBA from the University of Cincinnati (Ohio).

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
EVOME MEDICAL TECHNOLOGIES INC -.--%	2024-06-13	0 ( -.--% )	- $	2024-05-30

Wayne C. Anderson active positions

Companies	Position	Start
EVOME MEDICAL TECHNOLOGIES INC.	Director/Board Member	2024-02-13

All active positions of Wayne C. Anderson

Former positions of Wayne C. Anderson

Companies	Position	End
Ferring Pharmaceuticals, Inc. Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ.	Chief Executive Officer	2010-01-01

See the detail of Wayne C. Anderson's experience

Training of Wayne C. Anderson

The Ohio University	Undergraduate Degree
University of Cincinnati (Ohio)	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wayne C. Anderson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
EVOME MEDICAL TECHNOLOGIES INC.	Health Technology

Private companies	1
Ferring Pharmaceuticals, Inc. Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ.	Health Technology